Skin of Color
The patient history can hold the clue to diagnosis and management of CSVV.
Brian Robert Keegan MD, PhD and Evan H. Schlam, MDr
From injection site and infusion reactions to more serious autoimmune disorders, here's an evidence-based review of the immunologic and hematologic AEs associated with anti-TNF therapy.
Martha H. Viera, MD, Sadegh Amini, MD, Ran Huo, BS, Sailesh Konda, BS, and Brian Berman, MD, PhDr
Dermatologists aren't expected to be psychotherapists, but they must be prepared to refer high-risk patients and to offer therapeutic support and understanding to others.
Richard G. Fried, MD, PhDr
One laser expert shares his view of what's in store for body contouring procedures.
Ted Pigeon, Associate Editor
Prospective data are lacking, but early findings suggest little if any risk of density-loss among patients on long-term therapy.
Thomas E. Carson, MD
Paul Winnington, Editor-in-Chief
In times such as these, physicians have more questions about the future of their practices and how best to maintain financial stability.
Bruce S. Maller
Next month, the Federal government's official push for e-prescribing begins. Here are some tips to maximize your gains, even if you don't have an EMR system in place.
Mark Kaufmann, MD
Avoid the frustration of suture breakage in high-tension areas with a simple but effective technique.
Charles F. Knapp, III, BS and Basil S. Cherpelis, MD
Early diagnosis and treatment are essential for reducing the burden of psoriatic arthritis and the likelihood of disability.
Jerry Bagel, MD
Data shed light on risk factors associated with aggressive SCC, allowing dermatologists to identify and properly follow high-risk patients.
Jonathan Wolfe, MD
Joel Schlessinger, MD
Here are five ways patients may be affected by the dwindling economy and steps your practice can take to minimize the impact.
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.